Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.23 million.

GUIDANCE:

Rockwell Medical sees FY2024 revenue of $90-94 million, versus the consensus of $88.974 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.